Colgate-Palmolive Company is a consumer goods manufacturer operating in two segments: Oral, Personal and Home Care, and Pet Nutrition. The company markets oral care products under brands including Colgate, Darlie, elmex, hello, meridol, Sorriso, and Tom’s of Maine, covering toothpastes, toothbrushes, mouthwashes, and pharmaceutical products for dental professionals. Its personal care portfolio includes liquid hand soaps, bar soaps, shower gels, deodorants, and skin health products under brands such as Palmolive, Protex, Softsoap, Irish Spring, Sanex, Lady Speed Stick, Speed Stick, EltaMD, Filorga, and PCA SKIN. Home care products include dishwashing liquids, household cleaners, and fabric conditioners under Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, Fluffy, and Cuddly. The Pet Nutrition segment, operated through Hill’s Pet Nutrition, offers specialty pet foods for dogs and cats under Hill’s Science Diet, Hill’s Prescription Diet, and Prime100. Products are sold globally to retailers, wholesalers, distributors, veterinarians, and direct-to-consumer channels. The company was founded in 1806.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Household & Personal Products Homepage colgatepalmolive.co.th
Sector Consumer Defensive IR page investor.colgatepalmolive.com
Tags
oral care, personal care, home care, pet nutrition, toothpaste, toothbrushes, hand soap, shower gel, deodorant, skin health, dishwashing liquid, household cleaner, Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, Palmolive, Protex, Softsoap, Irish Spring, Sanex, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, Fluffy, Cuddly, Hill’s Pet Nutrition, Hill’s Science Diet, Hill’s Prescription Diet, Prime100
Press page —

Metrics

Valuation  
Market cap $ 77.878B
Market cap (USD) $ 77.878B
P/E 38.27
PEG 6.27
P/BV 270.41
P/S 3.66
P/OCF 17.84
P/FCF 20.55
Dividend yield 2.2%
Turnover / mcap —
Returns  
ROE 1,603.0%
ROI 26.5%
ROIC 30.4%
Profit margin 10.5%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 6.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 2,494.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 23
Quality score 15.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 20.382B 20.101B 19.457B 17.967B 17.421B 16.471B 15.693B 15.544B 15.454B 15.195B 16.034B 17.277B 17.42B 17.085B 16.734B 15.564B 15.327B — — — 11.397B 10.584B 9.903B 9.294B 9.428B —
Net profit 2.132B 2.889B 2.3B 1.785B 2.166B 2.695B 2.367B 2.4B 2.024B 2.441B 1.384B 2.18B 2.241B 2.472B 2.431B 2.203B 2.291B 1.957B 1.737B 1.353B 1.351B 1.327B 1.421B 1.288B 1.147B 1.064B
Free cash flow 3.634B 3.546B 3.04B 1.86B 2.758B 3.31B 2.798B 2.62B 2.501B 2.548B 2.258B 2.541B 2.534B 2.631B 2.359B 2.661B 2.702B 1.555B 1.621B 1.345B 1.395B 1.406B 1.466B 1.268B 1.259B 1.17B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 79.02 90.91 79.71 78.79 85.34 85.51 68.84 59.52 75.45 65.44 66.62 69.19 65.21 104.54 92.39 80.37 82.15 68.54 80.05 65.86 — — — — — —
Price performance 12m -0.13 0.14 0.01 -0.08 -0 0.24 0.16 -0.21 0.15 -0.02 -0.04 0.06 -0.38 0.13 0.15 -0.02 0.2 -0.14 0.22 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 1.41B 1.48B 1.4B 1.44B 1.26B 1.3B 1.5B 1.59B 1.52B 1.68B
↳ YoY growth -1.1% +4.9% -5.4% +2.9% -12.2% +2.6% +16.0% +5.5% -4.1% +10.1%
↳ 5y CAGR -3.4% -2.4% -3.1% -1.5% -2.4% -1.7% +0.3% +2.5% +1.1% +5.8%
Borrowings, current (USD) 0.00 0.00 0.00 254M 9M 12M 14M 20M 652M 1.12B
Borrowings, non-current (USD) 6.52B 6.57B 6.35B 7.33B 7.33B 7.19B 8.74B 8.22B 7.29B 6.87B
Lease liabilities (USD) — — — 636M 613M 588M 505M 515M 563M 566M
Cash and deposits (USD) 1.32B 1.54B 726M 883M 888M 832M 775M 966M 1.1B 1.29B
Intangible assets (USD) 1.31B 1.34B 1.64B 2.67B 2.89B 2.46B 1.92B 1.89B 1.76B 1.54B
Right-of-use assets (USD) — — — 502M 521M 527M 478M 491M 529M 531M
Net debt (borrowings + leases - cash) (USD) 5.21B 5.03B 5.63B 7.34B 7.07B 6.96B 8.49B 7.79B 7.41B 7.26B
Cash flow detail
Operating cash flow (USD) 3.14B 3.05B 3.06B 3.13B 3.72B 3.33B 2.56B 3.75B 4.11B 4.2B
Purchases of property, plant and equipment (USD) -593M -553M -436M -335M -409M -567M -696M -705M -561M -564M
Change in receivables (cash effect) (USD) -17M -15M -79M 19M 138M -84M -227M -37M -56M -16M
Change in inventories (cash effect) (USD) -4M -8M -58M -77M -251M -72M -333M 194M -100M 109M
Change in payables (cash effect) (USD) 100M -96M 18M 36M 520M 14M -115M 309M 516M —
Share buybacks (cash effect) (USD) -1.34B -1.4B -1.24B -1.2B -1.48B -1.32B -1.31B -1.13B -1.74B -1.21B
Interest paid (cash effect) (USD) -162M -150M -194M -185M -188M -194M -151M -280M -302M -270M
Income taxes paid (cash effect) (USD) -932M -1.04B -847M -803M -845M -890M -945M -937M -933M -913M
Share-based compensation (USD) 123M 127M 109M 100M 107M 135M 125M 122M 135M 155M
Operating cash flow before change in receivables (USD) 3.16B 3.07B 3.14B 3.11B 3.58B 3.41B 2.78B 3.78B 4.16B 4.21B
Free cash flow (OCF - PPE - intangibles) (USD) 2.55B 2.5B 2.62B 2.8B 3.31B 2.76B 1.86B 3.04B 3.55B 3.63B
Income detail
Research and development expense (USD) 289M 285M 277M 281M 290M 307M 320M 343M 355M 366M
↳ 5y CAGR +2.0% +1.9% +0.7% +0.3% +1.1% +1.2% +2.3% +4.4% +4.8% +4.8%
Total comprehensive income (USD) 2.34B 2.52B 2.37B 2.44B 2.79B 2.3B 2.29B 2.53B 2.76B 2.61B
Comprehensive income to owners (USD) 2.21B 2.35B 2.23B 2.28B 2.62B 2.13B 2.12B 2.42B 2.61B 2.47B
Reported Feb 23, 2017 Feb 15, 2018 Feb 21, 2019 Feb 21, 2020 Feb 18, 2021 Feb 17, 2022 Feb 16, 2023 Feb 15, 2024 Feb 13, 2025 Feb 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

CWG Season 51 Registration Opens Bull 0 Bear 0 Routine

This content is not accessible because cookies are disabled. To access this content, cookies must be enabled. Please click the button below, enable cookies, and then refresh the page. You can manage your cookie preferences at any time using the cookie settings tool.

Enable cookies

Colgate Palmolive

Colgate Palmolive

Search

Menu

Suggested Searches

Load more text

Learn More

No Results Copy RTE

Result Page Url

multi_match

Invalid Query Message

Explore Content

Stories

Sustainability Reports

Policies

Press Releasesopens in a new tab

Resources

Safety Data Sheets

For Suppliers

Product Ingredientsopens in a new tab

Open Positionsopens in a new tab

  1. Home

  2. News & Updates

  3. CWG Season 51 Registration Opens

ARTICLE

Colgate Women’s Games Registration Opens for Season 51

  • November 2, 2026

Kids runing on maraton

Category

The Nation's Longest-Running Indoor Track & Field Series for Girls and Women Returns to The Armory in New York City in December 2026


Registration is now open for the 51st season of Colgate Women’s Games (CWG), the nation’s longest-running indoor track & field series for girls and women. With the enduring support of Colgate-Palmolive, Colgate Women’s Games has been inspiring women and girls on and off the track since its founding in 1974 by legendary track and field coach Fred Thompson.

“Season after season, I've watched girls walk onto this track unsure of themselves and walk off as leaders,” said Cheryl Toussaint, Meet Director, Colgate Women’s Games. “CWG is built on more than athletics. It's mentorship, discipline and the kind of confidence that athletes carry with them into school, careers and beyond. That spirit was on full display during our 50th anniversary, and it only grows stronger every year. If your daughter, sister, niece or friend has been thinking about it, Season 51 is the season to get involved. Every woman and girl is welcome to come out, participate, and discover what she's capable of.”

Participating athletes have the opportunity to win one of more than 100 educational scholarships awarded by Colgate-Palmolive each year, in $2,000, $1,000 and $500 denominations, based on points earned throughout the series.

New this season, Colgate Women’s Games is officially a USA Track & Field-sanctioned event.  Eligible performances achieved at CWG may now be used for national rankings, record consideration and qualifying standards for championships and other sanctioned competitions. This designation elevates the profile and prestige of CWG as a nationally recognized meet. Participants can learn more at usatf.org/sanctions.opens in a new tab

“As part of our 50th season, we saw firsthand the strong connection of Colgate Women’s Games alumnae, and their participation reinforced my belief that the future for these women is unlimited,” said Dana Bolden, Chief Communications Officer, Colgate-Palmolive. “As we enter a new era, we remain committed to collaborating with our communities to empower young women and help them realize that future for themselves.”

This season follows a notable recognition for the program: Colgate-Palmolive was named a finalist for the Corporate Community Impact Award at the 2026 ESPN Sports Humanitarian Awards, honoring its five-decade impact on the lives of girls and young women. With over 5,000 educational scholarships awarded and countless lives changed for the better, this recognition is a testament to that enduring legacy.

Introduced during the 50th Anniversary Season, Colgate-Palmolive awarded $10,000 each to five eligible track clubs that align with CWG’s core mission through the “Ready, Set, Dream” Grant. Building on that foundation, Colgate-Palmolive is expanding its commitment in Season 51 by awarding an additional $10,000 grant to another deserving track club.

girl jumping on maraton

Register Now

This season’s competition will take place at The Nike Track & Field Center at The Armory in New York City. Athletes can follow these instructionsopens in a new tab to register to compete now through January 2, 2027. Those who complete a digital entry form and attend one of the in-person registration events will receive a complimentary competitor’s packet including a CWG t-shirt and bib number, and a complimentary family care package of Colgate-Palmolive health and hygiene products.

Find more information on Colgate Women’s Games, visit www.ColgateWomensGames.comopens in a new tab and follow us on Instagramopens in a new tab for updates throughout the season.

Related Stories

Your Questions, Answered

Contact us FAQs

Footer

Colgate-Palmolive

Colgate-Palmolive


Get in Touch

Visit us on Linked In. Opens in a new tab

opens in a new tab

Visit us on Instagram. Opens in a new tab

opens in a new tab

Visit us on Youtube. Opens in a new tab

opens in a new tab

Visit us on X. Opens in a new tab

opens in a new tab

Explore Colgate-Palmolive

Resources

Our Sites

Legal & Privacy

© 2026 Colgate-Palmolive Company. All Rights Reserved.

Colgate-Palmolive Announces 3rd Quarter 2026 Results Bull 3 Bear 0 Results

October 30, 2026

3Q 2026 Earnings Press Release 251.3 KB

NEW YORK--(BUSINESS WIRE)--Oct. 30, 2026-- Colgate-Palmolive Company (NYSE:CL):

  • Net sales increased 4.6%; Organic sales* increased 3.6%, including a 0.2% negative impact from lower private label pet food sales

  • GAAP EPS increased 3% to $0.94; Base Business EPS* increased 7% to $0.97

  • GAAP Gross profit margin increased 80 basis points to 60.2%; Base Business Gross profit margin* increased 90 basis points to 60.3%

  • Net cash provided by operations was $2,913 million for the first nine months of 2026

  • The Company’s leadership in toothpaste continued with its global market share at 41.4% year to date

  • The Company’s leadership in manual toothbrushes continued with its global market share at 33.1% year to date

  • The Company narrowed its sales guidance and raised its gross profit margin and Base Business earnings per share guidance for full year 2026

| Third Quarter Total Company Results (GAAP) |

| ($ in millions except per share amounts) | 2026 | 2025 | Change |

| Net Sales | $5,369 | $5,131 | +4.6% |

| EPS (diluted) | $0.94 | $0.91 | +3% |

| | | | |

| | | | |

| Third Quarter Total Company Results (Base Business - Non-GAAP)* |

| | 2026 | 2025 | Change |

| Organic Sales Growth | +3.6% |

| Base Business EPS (diluted) | $0.97 | $0.91 | +7% |

| *Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |

Colgate-Palmolive Company (NYSE:CL) today reported results for third quarter 2026. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business third quarter results, “Our growth momentum continued, delivering another strong quarter of broad-based top- and bottom-line growth with net sales and organic sales increasing in all four categories and in four of five divisions. We were particularly pleased to have delivered our fourth quarter of sequential improvement in worldwide volume growth, while delivering strong pricing growth in the third quarter. As was the case last quarter, gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year.

“We remain focused on executing our 2030 strategy, with an emphasis on driving premium, science-based innovation, and we continue to invest behind our brands globally supported by another double-digit increase in advertising this quarter.

“Despite consumer uncertainty and ongoing macroeconomic volatility, our proactive focus on driving growth while building flexibility into our P&L gives us confidence we can navigate these challenges while continuing to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.”

Full Year 2026 GuidanceBased on current spot rates:

  • The Company now expects net sales to be up 4% to 5% (versus 2% to 6% previously), including a low-single-digit positive impact from foreign exchange.

  • The Company now expects organic sales growth to be broadly in line with its nine-month performance (versus 1% to 4% previously). This includes the impact from our exit from the private label pet food business.

  • On a GAAP basis, the Company now expects gross profit margin to be up (versus roughly flat previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.

  • On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be up (versus roughly flat previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also now expects 5% to 7% earnings per share growth (versus mid-single-digit growth previously).

Divisional PerformanceSee attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

| Third Quarter Sales Growth By Division (% change 3Q 2026 vs. 3Q 2025 except % of Total Company Sales) | | |

| | % of Total Company Sales | Net Sales | Organic Sales* | Volume | Pricing | FX |

| North America(1) | 17% | -1.7% | -1.6% | -3.7% | +2.2% | -0.2% |

| Latin America | 25% | +12.5% | +6.0% | +3.9% | +2.1% | +6.5% |

| Europe, Middle East & Africa(1) | 21% | +1.4% | +2.7% | +3.5% | -0.9% | -1.2% |

| Asia Pacific(1) | 15% | +3.5% | +4.6% | +1.9% | +2.8% | -1.1% |

| Hill’s Pet Nutrition | 22% | +5.6% | +5.7% | +1.8% | +3.9% | -0.1% |

| | | | | | | |

| Total Company | 100% | +4.6% | +3.6% | +1.7% | +2.0% | +1.0% |

| Table may not sum due to rounding. |

| |

| (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. Recast historical geographic segment information can be found on the Company's website. |

| |

| *Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |

| Third Quarter Operating Profit By Division ($ in millions) | |

| | 3Q 2026 | % Change vs 3Q 2025 | % to Net Sales | Change in basis points vs 3Q 2025 % to Net Sales |

| North America(1) | $177 | -11% | 19.5% | -210 |

| Latin America | $392 | 17% | 29.6% | +100 |

| Europe, Middle East & Africa(1) | $262 | 8% | 23.2% | +140 |

| Asia Pacific(1) | $211 | -1% | 26.4% | -110 |

| Hill’s Pet Nutrition | $267 | 5% | 22.2% | -20 |

| | | | | |

| Total Company, As Reported | $1,088 | 3% | 20.3% | -30 |

| Total Company, Base Business* | $1,117 | 5% | 20.8% | +20 |

| (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. |

| |

| *Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |

Prepared Materials and Webcast InformationAt approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding third quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

At 8:30 a.m. ET today, the Company will host a conference call regarding third quarter results. To access this call as a webcast, please go to Colgate-Palmolive’s website at www.colgatepalmolive.com.

About Colgate-PalmoliveColgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership and innovation in promoting community wellbeing and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com. CL-E

Market Share InformationManagement uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. Except as otherwise noted, all market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking StatementsThis press release and the related prepared materials and webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, category growth rates, the impact of foreign exchange, the impact of developments in global trade relations and tariffs, the impact of geopolitical events and tensions, wars and military conflicts, such as in Ukraine and the Middle East, cost reduction plans (including the Strategic Growth and Productivity Program), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of October 30, 2026. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial MeasuresThe following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

  • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the Strategic Growth and Productivity Program and the ERISA litigation matter and acquisition-related costs.

  • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.

  • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release and the related prepared materials and webcast discuss Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and nine months ended September 30, 2026 versus 2025 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and nine months ended September 30, 2026 and 2025 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the nine months ended September 30, 2026 and 2025 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for third quarter results.)

| | | | | Table 1 |

| Colgate-Palmolive Company |

| |

| Condensed Consolidated Statements of Income |

| |

| For the Three Months Ended September 30, 2026 and 2025 |

| |

| (Dollars in Millions Except Per Share Amounts) (Unaudited) |

| |

| | | 2026 | | 2025 |

| | | | | |

| Net sales | | $ | 5,369 | | | $ | 5,131 | |

| | | | | |

| Cost of sales | | | 2,136 | | | | 2,082 | |

| | | | | |

| Gross profit | | | 3,233 | | | | 3,049 | |

| | | | | |

| Gross profit margin | | | 60.2 | % | | | 59.4 | % |

| | | | | |

| Selling, general and administrative expenses | | | 2,111 | | | | 1,971 | |

| | | | | |

| Other (income) expense, net | | | 34 | | | | 19 | |

| | | | | |

| Operating profit | | | 1,088 | | | | 1,059 | |

| | | | | |

| Operating profit margin | | | 20.3 | % | | | 20.6 | % |

| | | | | |

| Non-service related postretirement costs | | | 24 | | | | 21 | |

| | | | | |

| Interest expense | | | 62 | | | | 67 | |

| | | | | |

| Interest income | | | 17 | | | | 21 | |

| | | | | |

| Income before income taxes | | | 1,019 | | | | 992 | |

| | | | | |

| Provision for income taxes | | | 240 | | | | 226 | |

| | | | | |

| Effective tax rate | | | 23.6 | % | | | 22.8 | % |

| | | | | |

| Net income including noncontrolling interests | | | 779 | | | | 766 | |

| | | | | |

| Less: Net income attributable to noncontrolling interests | | | 28 | | | | 31 | |

| | | | | |

| Net income attributable to Colgate-Palmolive Company | | $ | 751 | | | $ | 735 | |

| | | | | |

| Earnings per common share | | | | |

| Basic | | $ | 0.94 | | | $ | 0.91 | |

| Diluted | | $ | 0.94 | | | $ | 0.91 | |

| | | | | |

| Supplemental Income Statement Information | | | | |

| Average common shares outstanding | | | | |

| Basic | | | 796.9 | | | | 807.8 | |

| Diluted | | | 799.7 | | | | 810.2 | |

| | | | | |

| Advertising | | $ | 775 | | | $ | 674 | |

| | | | | Table 2 |

| Colgate-Palmolive Company |

| |

| Condensed Consolidated Statements of Income |

| |

| For the Nine Months Ended September 30, 2026 and 2025 |

| |

| (Dollars in Millions Except Per Share Amounts) (Unaudited) |

| |

| | | 2026 | | 2025 |

| | | | | |

| Net sales | | $ | 16,055 | | | $ | 15,152 | |

| | | | | |

| Cost of sales | | | 6,300 | | | | 6,047 | |

| | | | | |

| Gross profit | | | 9,755 | | | | 9,105 | |

| | | | | |

| Gross profit margin | | | 60.8 | % | | | 60.1 | % |

| | | | | |

| Selling, general and administrative expenses | | | 6,316 | | | | 5,833 | |

| | | | | |

| Other (income) expense, net | | | 370 | | | | 58 | |

| | | | | |

| Operating profit | | | 3,069 | | | | 3,214 | |

| | | | | |

| Operating profit margin | | | 19.1 | % | | | 21.2 | % |

| | | | | |

| Non-service related postretirement costs | | | 70 | | | | 116 | |

| | | | | |

| Interest expense | | | 186 | | | | 203 | |

| | | | | |

| Interest income | | | 50 | | | | 56 | |

| | | | | |

| Income before income taxes | | | 2,863 | | | | 2,951 | |

| | | | | |

| Provision for income taxes | | | 682 | | | | 685 | |

| | | | | |

| Effective tax rate | | | 23.8 | % | | | 23.2 | % |

| | | | | |

| Net income including noncontrolling interests | | | 2,181 | | | | 2,266 | |

| | | | | |

| Less: Net income attributable to noncontrolling interests | | | 91 | | | | 97 | |

| | | | | |

| Net income attributable to Colgate-Palmolive Company | | $ | 2,090 | | | $ | 2,169 | |

| | | | | |

| Earnings per common share | | | | |

| Basic(1) | | $ | 2.61 | | | $ | 2.68 | |

| Diluted(1) | | $ | 2.61 | | | $ | 2.67 | |

| | | | | |

| Supplemental Income Statement Information | | | | |

| Average common shares outstanding | | | | |

| Basic | | | 799.5 | | | | 810.0 | |

| Diluted | | | 802.2 | | | | 812.8 | |

| | | | | |

| Advertising | | $ | 2,286 | | | $ | 2,020 | |

| Note: |

| (1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period. |

| | | | | | | Table 3 |

| Colgate-Palmolive Company |

| |

| Condensed Consolidated Balance Sheets |

| |

| As of September 30, 2026, December 31, 2025 and September 30, 2025 |

| |

| (Dollars in Millions) (Unaudited) |

| | | | | | | |

| | | September 30, | | December 31, | | September 30, |

| | | 2026 | | 2025 | | 2025 |

| Cash and cash equivalents | | $ | 1,527 | | | $ | 1,288 | | | $ | 1,279 | |

| Receivables, net | | | 1,901 | | | | 1,675 | | | | 1,807 | |

| Inventories | | | 2,182 | | | | 2,032 | | | | 2,109 | |

| Other current assets | | | 747 | | | | 714 | | | | 844 | |

| Property, plant and equipment, net | | | 4,613 | | | | 4,660 | | | | 4,560 | |

| Goodwill | | | 3,080 | | | | 3,122 | | | | 3,702 | |

| Other intangible assets, net | | | 1,472 | | | | 1,536 | | | | 1,889 | |

| Other assets | | | 1,220 | | | | 1,303 | | | | 1,323 | |

| Total assets | | $ | 16,742 | | | $ | 16,330 | | | $ | 17,513 | |

| | | | | | | |

| Total debt | | $ | 7,716 | | | $ | 7,988 | | | $ | 8,419 | |

| Other current liabilities | | | 6,107 | | | | 5,736 | | | | 5,383 | |

| Other non-current liabilities | | | 2,279 | | | | 2,241 | | | | 2,473 | |

| Total liabilities | | | 16,102 | | | | 15,965 | | | | 16,275 | |

| Total Colgate-Palmolive Company shareholders’ equity | | | 288 | | | | 54 | | | | 856 | |

| Noncontrolling interests | | | 352 | | | | 311 | | | | 382 | |

| Total liabilities and equity | | $ | 16,742 | | | $ | 16,330 | | | $ | 17,513 | |

| | | | | | | |

| Supplemental Balance Sheet Information | | | | | | |

| Debt less cash, cash equivalents and marketable securities(1) | | $ | 6,104 | | | $ | 6,593 | | | $ | 6,947 | |

| Working capital % of sales | | | (6.3 | )% | | | (7.0 | )% | | | (4.0 | )% |

| Note: |

| (1) Marketable securities of $85, $107 and $193 as of September 30, 2026, December 31, 2025 and September 30, 2025, respectively, are included in Other current assets. |

| | | | | Table 4 |

| Colgate-Palmolive Company |

| |

| Condensed Consolidated Statements of Cash Flows |

| |

| For the Nine Months Ended September 30, 2026 and 2025 |

| |

| (Dollars in Millions) (Unaudited) |

| | | | | |

| | | 2026 | | 2025 |

| Operating Activities | | | | |

| Net income including noncontrolling interests | | $ | 2,181 | | | $ | 2,266 | |

| Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | | |

| Depreciation and amortization | | | 470 | | | | 457 | |

| ERISA litigation matter | | | — | | | | 65 | |

| Restructuring and termination benefits, net of cash | | | 177 | | | | (15 | ) |

| Stock-based compensation expense | | | 141 | | | | 127 | |

| Deferred income taxes | | | 54 | | | | 8 | |

| Cash effects of changes in: | | | | |

| Receivables | | | (224 | ) | | | (180 | ) |

| Inventories | | | (104 | ) | | | 9 | |

| Accounts payable and other working capital | | | 254 | | | | 30 | |

| Other non-current assets | | | 48 | | | | 48 | |

| Other non-current liabilities | | | (84 | ) | | | (70 | ) |

| Net cash provided by (used in) operations | | | 2,913 | | | | 2,745 | |

| | | | | |

| Investing Activities | | | | |

| Capital expenditures | | | (400 | ) | | | (387 | ) |

| Purchases of marketable securities and investments | | | (163 | ) | | | (537 | ) |

| Proceeds from sale of marketable securities and investments | | | 187 | | | | 508 | |

| Payment for acquisition, net of cash acquired | | | — | | | | (293 | ) |

| Other investing activities | | | (5 | ) | | | (5 | ) |

| Net cash provided by (used in) investing activities | | | (381 | ) | | | (714 | ) |

| | | | | |

| Financing Activities | | | | |

| Short-term borrowing (repayment) less than 90 days, net | | | 947 | | | | 139 | |

| Principal payments on debt | | | (1,087 | ) | | | (655 | ) |

| Proceeds from issuance of debt | | | — | | | | 497 | |

| Dividends paid | | | (1,308 | ) | | | (1,300 | ) |

| Purchases of treasury shares | | | (927 | ) | | | (804 | ) |

| Proceeds from exercise of stock options | | | 178 | | | | 83 | |

| Other financing activities | | | (75 | ) | | | 145 | |

| Net cash provided by (used in) financing activities | | | (2,272 | ) | | | (1,895 | ) |

| | | | | |

| Effect of exchange rate changes on Cash and cash equivalents | | | (21 | ) | | | 47 | |

| Net increase (decrease) in Cash and cash equivalents | | | 239 | | | | 183 | |

| Cash and cash equivalents at beginning of the period | | | 1,288 | | | | 1,096 | |

| Cash and cash equivalents at end of the period | | $ | 1,527 | | | $ | 1,279 | |

| | | | | |

| Supplemental Cash Flow Information | | | | |

| Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | | | | |

| Net cash provided by operations | | $ | 2,913 | | | $ | 2,745 | |

| Less: Capital expenditures | | | (400 | ) | | | (387 | ) |

| Free cash flow before dividends | | $ | 2,513 | | | $ | 2,358 | |

| | | | | |

| | | | | |

| Income taxes paid | | $ | 648 | | | $ | 712 | |

| Interest paid | | $ | 205 | | | $ | 235 | |

| | | | | | | | | Table 5 |

| Colgate-Palmolive Company |

| | | | | |

| Segment Information |

| | | | | |

| For the Three and Nine Months Ended September 30, 2026 and 2025 |

| | | | | |

| (Dollars in Millions) (Unaudited) |

| | | | | | | | | |

| | | | | | | |

| | | Three Months Ended September 30, | | Nine Months Ended September 30, |

| | | 2026 | | 2025 | | 2026 | | 2025 |

| Net Sales | | | | | | | | |

| Oral, Personal and Home Care | | | | | | | | |

| | | | | | | | | |

| North America(1) | | $ | 905 | | | $ | 922 | | | $ | 2,684 | | | $ | 2,745 | |

| Latin America | | | 1,326 | | | | 1,178 | | | | 4,011 | | | | 3,528 | |

| Europe, Middle East & Africa(1) | | | 1,130 | | | | 1,115 | | | | 3,377 | | | | 3,204 | |

| Asia Pacific(1) | | | 802 | | | | 775 | | | | 2,388 | | | | 2,259 | |

| | | | | | | | | |

| Total Oral, Personal and Home Care | | | 4,164 | | | | 3,989 | | | | 12,461 | | | | 11,735 | |

| | | | | | | | | |

| Hill's Pet Nutrition | | | 1,205 | | | | 1,142 | | | | 3,594 | | | | 3,417 | |

| | | | | | | | | |

| Total Net Sales | | $ | 5,369 | | | $ | 5,131 | | | $ | 16,055 | | | $ | 15,152 | |

| | | | | | | | | |

| | | | | | | | | |

| | | Three Months Ended September 30, | | Nine Months Ended September 30, |

| | | 2026 | | 2025 | | 2026 | | 2025 |

| Operating Profit | | | | | | | | |

| Oral, Personal and Home Care | | | | | | | | |

| | | | | | | | | |

| North America(1) | | $ | 177 | | | $ | 199 | | | $ | 510 | | | $ | 583 | |

| Latin America | | | 392 | | | | 337 | | | | 1,211 | | | | 1,052 | |

| Europe, Middle East & Africa(1) | | | 262 | | | | 243 | | | | 791 | | | | 706 | |

| Asia Pacific(1) | | | 211 | | | | 213 | | | | 643 | | | | 620 | |

| | | | | | | | | |

| Total Oral, Personal and Home Care | | | 1,042 | | | | 992 | | | | 3,155 | | | | 2,961 | |

| | | | | | | | | |

| Hill's Pet Nutrition | | | 267 | | | | 255 | | | | 816 | | | | 778 | |

| Corporate(2) | | | (221 | ) | | | (189 | ) | | | (902 | ) | | | (523 | ) |

| | | | | | | | | |

| Total Operating Profit | | $ | 1,088 | | | $ | 1,059 | | | $ | 3,069 | | | $ | 3,214 | |

| Tables may not sum due to rounding. |

| |

| Notes: |

| (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. |

| |

| (2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. |

| |

| Corporate Operating profit (loss) for the three and nine months ended September 30, 2026 included charges resulting from the Strategic Growth and Productivity Program of $29 and $327, respectively. |

| |

| Corporate Operating profit (loss) for the nine months ended September 30, 2025 included charges resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9. |

| Table 6 |

| Colgate-Palmolive Company |

| |

| Geographic Sales Analysis Percentage Changes |

| |

| For the Three Months Ended September 30, 2026 vs. 2025 |

| |

| (Unaudited) |

| | | | | | |

| | | | | | |

| | | | | | |

| | | | | | COMPONENTS OF SALES CHANGE |

| | | | | | | | | | | |

| | | | | | | | | Pricing | | |

| | | | | | | | | Coupons | | |

| | | Sales | | | | | | Consumer & | | |

| | | Change | | Organic | | | | Trade | | Foreign |

| Region | | As Reported | | Sales Change | | Volume | | Incentives | | Exchange |

| | | | | | | | | | | |

| Total Company | | 4.6 | % | | 3.6 | % | | 1.7 | % | | 2.0 | % | | 1.0 | % |

| | | | | | | | | | | |

| North America(1) | | (1.7 | )% | | (1.6 | )% | | (3.7 | )% | | 2.2 | % | | (0.2 | )% |

| | | | | | | | | | | |

| Latin America | | 12.5 | % | | 6.0 | % | | 3.9 | % | | 2.1 | % | | 6.5 | % |

| | | | | | | | | | | |

| Europe, Middle East & Africa(1) | | 1.4 | % | | 2.7 | % | | 3.5 | % | | (0.9 | )% | | (1.2 | )% |

| | | | | | | | | | | |

| Asia Pacific(1) | | 3.5 | % | | 4.6 | % | | 1.9 | % | | 2.8 | % | | (1.1 | )% |

| | | | | | | | | | | |

| Total CP Products | | 4.4 | % | | 3.1 | % | | 1.6 | % | | 1.4 | % | | 1.3 | % |

| | | | | | | | | | | |

| Hill’s Pet Nutrition | | 5.6 | % | | 5.7 | % | | 1.8 | % | | 3.9 | % | | (0.1 | )% |

| | | | | | | | | | | |

| | | | | | | | | | | |

| Emerging Markets(2) | | 8.0 | % | | 5.4 | % | | 3.7 | % | | 1.7 | % | | 2.7 | % |

| | | | | | | | | | | |

| Developed Markets | | 2.0 | % | | 2.3 | % | | 0.1 | % | | 2.2 | % | | (0.3 | )% |

| Table may not sum due to rounding. |

| |

| Notes: |

| (1) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. |

| |

| (2) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe. |

| Table 7 |

| Colgate-Palmolive Company |

| |

| Geographic Sales Analysis Percentage Changes |

| |

| For the Nine Months Ended September 30, 2026 vs. 2025 |

| |

| (Unaudited) |

| | | | | | | |

| | | | | | | |

| | | | | | | |

| | | | | | | COMPONENTS OF SALES CHANGE |

| | | | | | | | | | | | | |

| | | | | | | | | | | Pricing | | |

| | | | | | | | | | | Coupons | | |

| | | Sales | | | | | | | | Consumer & | | |

| | | Change | | Organic | | As Reported | | Organic | | Trade | | Foreign |

| Region | | As Reported | | Sales Change | | Volume(1) | | Volume | | Incentives | | Exchange |

| | | | | | | | | | | | | |

| Total Company | | 6.0 | % | | 3.0 | % | | 1.2 | % | | 1.0 | % | | 1.9 | % | | 2.8 | % |

| | | | | | | | | | | | | |

| North America(2) | | (2.2 | )% | | (2.3 | )% | | (3.6 | )% | | (3.6 | )% | | 1.4 | % | | 0.1 | % |

| | | | | | | | | | | | | |

| Latin America | | 13.7 | % | | 5.6 | % | | 2.8 | % | | 2.8 | % | | 2.7 | % | | 8.1 | % |

| | | | | | | | | | | | | |

| Europe, Middle East & Africa(2) | | 5.4 | % | | 2.7 | % | | 3.0 | % | | 3.0 | % | | (0.3 | )% | | 2.8 | % |

| | | | | | | | | | | | | |

| Asia Pacific(2) | | 5.7 | % | | 5.1 | % | | 3.5 | % | | 3.5 | % | | 1.6 | % | | 0.6 | % |

| | | | | | | | | | | | | |

| Total CP Products | | 6.2 | % | | 2.9 | % | | 1.5 | % | | 1.5 | % | | 1.4 | % | | 3.3 | % |

| | | | | | | | | | | | | |

| Hill’s Pet Nutrition | | 5.2 | % | | 3.3 | % | | 0.3 | % | | (0.6 | )% | | 3.9 | % | | 1.1 | % |

| | | | | | | | | | | | | |

| | | | | | | | | | | | | |

| Emerging Markets(3) | | 10.0 | % | | 5.4 | % | | 3.3 | % | | 3.3 | % | | 2.1 | % | | 4.6 | % |

| | | | | | | | | | | | | |

| Developed Markets | | 2.8 | % | | 1.0 | % | | (0.5 | )% | | (0.8 | )% | | 1.8 | % | | 1.4 | % |

| Table may not sum due to rounding. |

| |

| Notes: |

| (1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.2%, 0.8% and 0.3% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively. |

| |

| (2) The Company has recast its historical geographic segment information to conform to the reporting structure effective for the quarter ended March 31, 2026. |

| |

| (3) Emerging Markets include Latin America, Asia (excluding Japan), Africa, the Middle East and Eastern and Central Europe. |

| Table 8 |

| Colgate-Palmolive Company |

| |

| Non-GAAP Reconciliations |

| |

| For the Three Months Ended September 30, 2026 and 2025 |

| |

| (Dollars in Millions Except Per Share Amounts) (Unaudited) |

| | | | | | | |

| Gross Profit | | 2026 | | 2025 | | |

| Gross profit, GAAP | | $ | 3,233 | | | $ | 3,049 | | | |

| Strategic Growth and Productivity Program | | | 5 | | | | — | | | |

| Gross profit, non-GAAP | | $ | 3,238 | | | $ | 3,049 | | | |

| | | | | | | |

| | | | | | | Basis Point |

| Gross Profit Margin | | 2026 | | 2025 | | Change |

| Gross profit margin, GAAP | | | 60.2 | % | | | 59.4 | % | | 80 | |

| Strategic Growth and Productivity Program | | | 0.1 | % | | | — | % | | |

| Gross profit margin, non-GAAP | | | 60.3 | % | | | 59.4 | % | | 90 | |

| | | | | | | |

| | | | | | | |

| Selling, General and Administrative Expenses | | 2026 | | 2025 | | |

| Selling, general and administrative expenses, GAAP | | $ | 2,111 | | | $ | 1,971 | | | |

| Strategic Growth and Productivity Program | | | (9 | ) | | | — | | | |

| Selling, general and administrative expenses, non-GAAP | | $ | 2,102 | | | $ | 1,971 | | | |

| | | | | | | |

| | | | | | | Basis Point |

| Selling, General and Administrative Expenses as a Percentage of Net Sales | | 2026 | | 2025 | | Change |

| Selling, general and administrative expenses as a percentage of Net sales, GAAP | | | 39.3 | % | | | 38.4 | % | | 90 | |

| Strategic Growth and Productivity Program | | | (0.2 | )% | | | — | % | | |

| Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | | | 39.1 | % | | | 38.4 | % | | 70 | |

| | | | | | | |

| | | | | | | |

| Other (Income) Expense, Net | | 2026 | | 2025 | | |

| Other (income) expense, net, GAAP | | $ | 34 | | | $ | 19 | | | |

| Strategic Growth and Productivity Program | | | (15 | ) | | | — | | | |

| Other (income) expense, net, non-GAAP | | $ | 19 | | | $ | 19 | | | |

| | | | | | | |

| | | | | | | |

| Operating Profit | | 2026 | | 2025 | | % Change |

| Operating profit, GAAP | | $ | 1,088 | | | $ | 1,059 | | | 3 | % |

| Strategic Growth and Productivity Program | | | 29 | | | | — | | | |

| Operating profit, non-GAAP | | $ | 1,117 | | | $ | 1,059 | | | 5 | % |

| | | | | | | |

| | | | | | | Basis Point |

| Operating Profit Margin | | 2026 | | 2025 | | Change |

| Operating profit margin, GAAP | | | 20.3 | % | | | 20.6 | % | | (30 | ) |

| Strategic Growth and Productivity Program | | | 0.5 | % | | | — | % | | |

| Operating profit margin, non-GAAP | | | 20.8 | % | | | 20.6 | % | | 20 | |

| | | | | | | |

| Non-Service Related Postretirement Costs | | 2026 | | 2025 | | |

| Non-service related postretirement costs, GAAP | | $ | 24 | | | $ | 21 | | | |

| Strategic Growth and Productivity Program | | | (1 | ) | | | — | | | |

| Non-service related postretirement costs, non-GAAP | | $ | 23 | | | $ | 21 | | | |

| Note: The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |

| Table 8 |

| Continued |

| Colgate-Palmolive Company |

| |

| Non-GAAP Reconciliations |

| |

| For the Three Months Ended September 30, 2026 |

| |

| (Dollars in Millions Except Per Share Amounts) (Unaudited) |

| | | | | | | | | | | | | | | | | |

| | | 2026 |

| | | Income Before****Income Taxes | | Provision For Income Taxes(1) | | Net IncomeIncludingNoncontrolling****Interests | | Less: Income Attributable to Noncontrolling Interests | | Net IncomeAttributable ToColgate- Palmolive****Company | | Effective Income****Tax Rate(2) | | Diluted Earnings****Per Share |

| As Reported GAAP | | $ | 1,019 | | $ | 240 | | $ | 779 | | $ | 28 | | $ | 751 | | 23.6 | % | | $ | 0.94 |

| Strategic Growth and Productivity Program | | | 30 | | | 3 | | | 26 | | | — | | | 26 | | (0.3 | )% | | | 0.03 |

| Non-GAAP | | $ | 1,049 | | $ | 244 | | $ | 805 | | $ | 28 | | $ | 777 | | 23.3 | % | | $ | 0.97 |

| The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |

| |

| Notes: |

| (1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |

| |

| (2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |

| Table 9 |

| Colgate-Palmolive Company |

| |

| Non-GAAP Reconciliations |

| |

| For the Nine Months Ended September 30, 2026 and 2025 |

| |

| (Dollars in Millions Except Per Share Amounts) (Unaudited) |

| | | | | | | |

| Gross Profit | | 2026 | | 2025 | | |

| Gross profit, GAAP | | $ | 9,755 | | | $ | 9,105 | | | |

| Strategic Growth and Productivity Program | | | 7 | | | | — | | | |

| Gross profit, non-GAAP | | $ | 9,762 | | | $ | 9,105 | | | |

| | | | | | | |

| | | | | | | |

| Selling, General and Administrative Expenses | | 2026 | | 2025 | | |

| Selling, general and administrative expenses, GAAP | | $ | 6,316 | | | $ | 5,833 | | | |

| Strategic Growth and Productivity Program | | | (20 | ) | | | — | | | |

| ERISA litigation matter | | | — | | | | (15 | ) | | |

| Selling, general and administrative expenses, non-GAAP | $ | 6,296 | | | $ | 5,817 | | | |

| | | | | | | |

| | | | | | | Basis Point |

| Selling, General and Administrative Expenses as a Percentage of Net Sales | 2026 | | 2025 | | Change |

| Selling, general and administrative expenses as a percentage of Net sales, GAAP | | 39.3 | % | | | 38.5 | % | | 80 | |

| Strategic Growth and Productivity Program | | | (0.1 | )% | | | — | % | | |

| ERISA litigation matter | | | — | % | | | (0.1 | )% | | |

| Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | | 39.2 | % | | | 38.4 | % | | 80 | |

| | | | | | | |

| Other (Income) Expense, Net | | 2026 | | 2025 | | |

| Other (income) expense, net, GAAP | | $ | 370 | | | $ | 58 | | | |

| Strategic Growth and Productivity Program | | | (300 | ) | | | — | | | |

| Acquisition-related costs | | | — | | | | (9 | ) | | |

| Other (income) expense, net, non-GAAP | | $ | 70 | | | $ | 48 | | | |

| | | | | | | |

| Operating Profit | | 2026 | | 2025 | | % Change |

| Operating profit, GAAP | | $ | 3,069 | | | $ | 3,214 | | | (5 | )% |

| Strategic Growth and Productivity Program | | | 327 | | | | — | | | |

| ERISA litigation matter | | | — | | | | 15 | | | |

| Acquisition-related costs | | | — | | | | 9 | | | |

| Operating profit, non-GAAP | | $ | 3,396 | | | $ | 3,240 | | | 5 | % |

| | | | | | | |

| | | | | | | Basis Point |

| Operating Profit Margin | | 2026 | | 2025 | | Change |

| Operating profit margin, GAAP | | | 19.1 | % | | | 21.2 | % | | (210 | ) |

| Strategic Growth and Productivity Program | | | 2.1 | % | | | — | % | | |

| ERISA litigation matter | | | — | % | | | 0.1 | % | | |

| Acquisition-related costs | | | — | % | | | 0.1 | % | | |

| Operating profit margin, non-GAAP | | | 21.2 | % | | | 21.4 | % | | (20 | ) |

| |

| Non-Service Related Postretirement Costs | | 2026 | | 2025 | | |

| Non-service related postretirement costs, GAAP | | $ | 70 | | | $ | 116 | | | |

| Strategic Growth and Productivity Program | | | (6 | ) | | | — | | | |

| ERISA litigation matter | | | — | | | | (50 | ) | | |

| Non-service related postretirement costs, non-GAAP | | $ | 64 | | | $ | 66 | | | |

| Note: The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |

| Table 9 |

| Continued |

| Colgate-Palmolive Company |

| |

| Non-GAAP Reconciliations |

| |

| For the Nine Months Ended September 30, 2026 and 2025 |

| |

| (Dollars in Millions Except Per Share Amounts) (Unaudited) |

| | | | | | | | | | | | | | | | |

| | 2026 |

| | Income Before****Income Taxes | | Provision For Income Taxes(1) | | Net IncomeIncludingNoncontrolling****Interests | | Less: Income Attributable to Noncontrolling Interests | | Net IncomeAttributable ToColgate- Palmolive****Company | | Effective Income****Tax Rate(2) | | Diluted Earnings****Per Share |

| As Reported GAAP | $ | 2,863 | | $ | 682 | | $ | 2,181 | | $ | 91 | | $ | 2,090 | | 23.8 | % | | $ | 2.61 |

| Strategic Growth and Productivity Program | | 333 | | | 64 | | | 269 | | | 1 | | | 268 | | (0.5 | )% | | | 0.33 |

| Non-GAAP | $ | 3,196 | | $ | 746 | | $ | 2,450 | | $ | 91 | | $ | 2,359 | | 23.3 | % | | $ | 2.94 |

| | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | |

| | 2025 |

| | Income Before****Income Taxes | | Provision For Income Taxes(1) | | Net IncomeIncludingNoncontrolling****Interests | | Less: Income Attributable to Noncontrolling Interests | | Net IncomeAttributable ToColgate- Palmolive****Company | | Effective Income****Tax Rate(2) | | Diluted Earnings****Per Share |

| As Reported GAAP | $ | 2,951 | | $ | 685 | | $ | 2,266 | | $ | 97 | | $ | 2,169 | | 23.2 | % | | $ | 2.67 |

| ERISA litigation matter | | 65 | | | 12 | | | 53 | | | — | | | 53 | | — | % | | | 0.06 |

| Acquisition-related costs | | 9 | | | 2 | | | 7 | | | — | | | 7 | | — | % | | | 0.01 |

| Non-GAAP | $ | 3,027 | | $ | 702 | | $ | 2,325 | | $ | 97 | | $ | 2,228 | | 23.2 | % | | $ | 2.74 |

| The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding. |

| |

| Notes: |

| (1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |

| |

| (2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |

View source version on businesswire.com: https://www.businesswire.com/news/home/20261030142821/en/

Investor Relations: [email protected]

Communications: [email protected]

Source: Colgate-Palmolive Company

Your Questions, Answered

Contact us FAQs

October 16, 2026

NEW YORK--(BUSINESS WIRE)--Oct. 16, 2026-- Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 third quarter earnings conference call on Friday, October 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Executive Vice President, Investor Relations, Claire Ross. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate’s website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate’s website.

Prompts

Colgate-Palmolive Company (ticker CL), listed in United States.

ETFs Holding Colgate-Palmolive Company

ETF Weight in ETF Shares Market value As of
DHLX 6.31% 59,970 $ 5.498M Jun 30, 2026
DIVL 2.92% 19,141 $ 1.755M Jun 30, 2026
EMOP 2.53% 585,984 $ 53.723M Jun 30, 2026
SEIQ 2.39% 173,255 $ 15.884M Jun 30, 2026
SELV 2.24% 59,958 $ 5.497M Jun 30, 2026
BKDV 2.06% 415,787 $ 37.961M Jul 31, 2026
FDIV 2.00% 12,872 $ 1.175M Jul 31, 2026
SPCT 1.96% 14,425 $ 1.317M Jul 31, 2026
SAMT 1.89% 180,844 $ 16.58M Jun 30, 2026
GINX 1.89% 22,368 $ 2.009M Aug 31, 2026
FLV 1.67% 70,916 $ 6.37M Aug 31, 2026
TVAL 1.44% 162,486 $ 16.409M Nov 17, 2026
LOWV 1.37% 31,218 $ 2.804M Aug 31, 2026
BRCE 1.34% 5,541 $ 497.693K Aug 31, 2026
ROPE 1.23% 3,053 $ 300K Nov 18, 2026
AFGR 1.19% 9,730 $ 982.633K Nov 16, 2026
YALL 1.16% 8,496 $ 858.011K Nov 17, 2026
CAPE 1.16% 30,055 $ 2.755M Jun 30, 2026
DIVN 1.15% 39,353 $ 3.535M Aug 31, 2026
AVIE 1.08% 1,782 $ 179.964K Nov 16, 2026
ABFL 1.05% 60,704 $ 5.542M Jul 31, 2026
SGLC 0.94% 22,291 $ 2.002M Aug 31, 2026
LGDX 0.88% 11,952 $ 1.207M Nov 17, 2026
FTHI 0.86% 214,348 $ 21.647M Nov 16, 2026
FEGE 0.85% 237,990 $ 21.376M Aug 31, 2026
UPSD 0.80% 10,291 $ 939.568K Jul 31, 2026
GQI 0.78% 21,854 $ 2.004M Jun 30, 2026
HUSV 0.77% 4,353 $ 439.609K Nov 16, 2026
SFGV 0.66% 76,200 $ 7.59M Nov 18, 2026
DUHP 0.66% 1,312,757 $ 128.519M Nov 12, 2026
VFMF 0.64% 70,002 $ 6.288M Aug 31, 2026
FBCV 0.64% 12,384 $ 1.131M Jul 31, 2026
AIVL 0.58% 26,508 $ 2.43M Jun 30, 2026
SROI 0.58% 1,199 $ 109.469K Jul 31, 2026
AFLG 0.58% 53,104 $ 5.363M Nov 16, 2026
PY 0.51% 12,382 $ 1.135M Jun 30, 2026
LCTU 0.48% 53,934 $ 5.447M Nov 16, 2026
TCAL 0.48% 15,700 $ 1.586M Nov 17, 2026
SIXL 0.45% 9,594 $ 939.253K Nov 12, 2026
NQLT 0.41% 2,238 $ 201.017K Aug 31, 2026
FTLS 0.41% 106,342 $ 0.00 Nov 16, 2026
BAMG 0.33% 4,728 $ 424.669K Aug 31, 2026
GQQQ 0.33% 5,496 $ 550K Nov 18, 2026
ACLC 0.32% 11,617 $ 1.043M Aug 31, 2026
GSPY 0.30% 20,356 $ 2.056M Nov 17, 2026
GDMA 0.26% 4,936 $ 490K Nov 18, 2026
ENHU 0.24% 221 $ 22.319K Nov 16, 2026
THEQ 0.23% 834 $ 84.226K Nov 17, 2026
NBCR 0.22% 20,451 $ 1.837M Aug 31, 2026
AVSU 0.21% 9,949 $ 1.005M Nov 16, 2026
ACIO 0.20% 51,175 $ 4.672M Jul 31, 2026
ADME 0.20% 6,268 $ 572.268K Jul 31, 2026
IQSZ 0.19% 3,615 $ 330.05K Jul 31, 2026
XMAG 0.18% 3,911 $ 382.887K Nov 13, 2026
DXUV 0.18% 114,728 $ 11.232M Nov 12, 2026
TACU 0.18% 326 $ 32.923K Nov 17, 2026
ACVF 0.18% 2,997 $ 273.626K Jul 31, 2026
FFLV 0.17% 304 $ 27.755K Jul 31, 2026
GMOV 0.16% 1,925 $ 172.904K Aug 31, 2026
BDVL 0.16% 28,758 $ 2.904M Nov 16, 2026
AVLC 0.16% 25,182 $ 2.543M Nov 16, 2026
DFSU 0.15% 36,975 $ 3.62M Nov 12, 2026
AVUS 0.15% 220,519 $ 22.27M Nov 16, 2026
AVUQ 0.15% 6,381 $ 644.417K Nov 16, 2026
VSLU 0.15% 8,895 $ 815.494K Jun 30, 2026
RGLO 0.15% 5,364 $ 491.772K Jun 30, 2026
LDRX 0.14% 4,010 $ 360.178K Aug 31, 2026
AAUS 0.14% 7,153 $ 710K Nov 18, 2026
HBTA 0.14% 3,787 $ 340.148K Aug 31, 2026
IEDI 0.13% 390 $ 35.607K Jul 31, 2026
DFAU 0.12% 162,570 $ 15.916M Nov 12, 2026
DFAC 0.12% 1,086,625 $ 106.381M Nov 12, 2026
FLSP 0.12% 12,192 $ 1.118M Jun 30, 2026
VOXP 0.11% 69 $ 6,299.70 Jul 31, 2026
DCOR 0.11% 497,006 $ 48.657M Nov 12, 2026
NTSD 0.11% 419 $ 38.414K Jun 30, 2026
DFUS 0.11% 237,298 $ 23.231M Nov 12, 2026
NTSX 0.10% 15,506 $ 1.422M Jun 30, 2026
GDE 0.09% 5,059 $ 454.399K Aug 31, 2026
HCMT 0.09% 5,568 $ 508.358K Jul 31, 2026
APUE 0.08% 21,010 $ 1.887M Aug 31, 2026
MSLC 0.07% 31,108 $ 2.794M Aug 31, 2026
CSHP 0.05% 1,695 $ 171.178K Nov 16, 2026
GVLU 0.05% 1,182 $ 119.37K Nov 17, 2026
EBI 0.05% 3,651 $ 327.933K Aug 31, 2026
IALT 0.04% 32,686 $ 3.301M Nov 16, 2026
GEW 0.02% 372 $ 33.413K Aug 31, 2026
NPFE 0.00% 131 $ 11.96K Jul 31, 2026
FEAC 0.00% 2 $ 183.36 Jun 30, 2026
CORO 0.00% 503 $ 50.774K Nov 16, 2026
NTRL 0.00% 2,339 $ 0.00 Nov 16, 2026